Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells. This medication is commonly prescribed for hormone receptor-positive breast cancer.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication works by inhibiting the enzyme aromatase, which is responsible for producing estrogen. By reducing estrogen levels, Femara can slow the growth of cancer cells that rely on this hormone to proliferate.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headache, or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication. It is important to discuss any persistent or severe side effects with a healthcare provider.

Femara should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to share the medication with others. Women who are pregnant or planning to become pregnant should avoid taking Femara, as it can harm a developing fetus. Always consult a healthcare provider before starting or stopping any medication.

Femara may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including prescription and over-the-counter drugs, as well as herbal supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or side effects of Femara.